scispace - formally typeset
Open AccessJournal ArticleDOI

Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment.

Reads0
Chats0
TLDR
The carbapenems are widely regarded as the drugs of choice for the treatment of severe infections caused by ESBL-producing Enterobacteriaceae, although comparative clinical trials are scarce and the feasible modification of guidelines for community-onset bacteremia associated with different infections are prescribed.
About
This article is published in Saudi Journal of Biological Sciences.The article was published on 2015-01-01 and is currently open access. It has received 534 citations till now. The article focuses on the topics: Antibiotic resistance & Antimicrobial.

read more

Citations
More filters
Journal ArticleDOI

Clonal relatedness in the acquisition of intestinal carriage and transmission of multidrug resistant (MDR) Klebsiella pneumoniae and Escherichia coli and its risk factors among preterm infants admitted to the neonatal intensive care unit (NICU).

TL;DR: The prevalence of dominant aminoglycosides-resistant strains cluster in the NICU is alarming and awareness of and vigilance for the dominant cluster found will enable the reduction of cross-transmission amongst high-risk infants.
Journal ArticleDOI

Metabolic genes on conjugative plasmids are highly prevalent in Escherichia coli and can protect against antibiotic treatment

TL;DR: In this article , the presence of metabolic genes on 1,775 transferrable plasmids and compared their distribution to that of known antibiotic resistance genes, indicating that each gene type may impact the spread of the other across hosts.
Journal ArticleDOI

Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China

TL;DR: VAP was mainly caused by Gram-negative bacteria, with high antibiotic resistance rates, and plasmids played an important role in the spread of antibiotic resistance among bacteria.
References
More filters
Journal ArticleDOI

Extended-spectrum beta-lactamases: a clinical update.

TL;DR: Extended-spectrum β-lactamases represent an impressive example of the ability of gram-negative bacteria to develop new antibiotic resistance mechanisms in the face of the introduction of new antimicrobial agents.
Journal ArticleDOI

Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat

TL;DR: β-Lactamases continue to be the leading cause of resistance to β-lactam antibiotics among gram-negative bacteria and are now found in a significant percentage of Escherichia coli and Klebsiella pneumoniae strains in certain countries.
Journal ArticleDOI

A functional classification scheme for beta-lactamases and its correlation with molecular structure.

TL;DR: These enzymes are the major cause of bacterial resistance to b-lactam antibiotics and have been the subject of extensive microbiological, biochemical, and genetic investigations.
Journal ArticleDOI

beta-Lactamases in laboratory and clinical resistance.

TL;DR: The ability of the prevalent beta-Lactamases to cause resistance to widely used beta-lactams, whether resistance is accurately reflected in routine tests, and the extent to which the antibiogram for an organism can be used to predict the type of beta- lactamase that it produces are considered.
Related Papers (5)
Trending Questions (1)
What types of antibiotic resistance are there?

The paper discusses the production of extended-spectrum β-lactamases (ESBLs) as a significant resistance mechanism.